Corrigendum: New perspectives on an old grouping: the genomic and phenotypic variability of and the implications for calcium oxalate stone prevention.

[This corrects the article DOI: 10.3389/fmicb.2022.

New perspectives on an old grouping: The genomic and phenotypic variability of and the implications for calcium oxalate stone prevention.

is a unique bacterium with the ability to metabolize oxalate as a primary carbon source. Most kidney stones in humans are composed of calcium and oxalate. Therefore, supplementation with an oxalate-degrading bacterium may reduce stone burden in patients suffering from recurrent calcium oxalate-based urolithiasis.